Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.92
+0.39 (7.05%)
Oct 19, 2026, 4:00 PM EDT - Market closed
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $634.77 million as of October 19, 2026. It is the 13,004th most valuable company in the world and the 2,563rd biggest in the United States. Its market cap has increased by 38.63% in one year.
Market Cap
634.77M
Enterprise Value
277.25M
1-Year Change
38.63%
Global Rank
Country Rank
#2,563 United States
Category
ChartMarket Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $754.10M to $634.77M, a decrease of -15.82%. That is a compound annual growth rate of -1.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 634.77M | 44.46% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Attovia Therapeutics | 626.79M |
| Candel Therapeutics | 626.69M |
| Prime Medicine | 617.33M |
| Wave Life Sciences | 616.76M |
| Nuvectis Pharma | 606.02M |
| Avalo Therapeutics | 604.41M |
| Zevra Therapeutics | 590.27M |
| Olema Pharmaceuticals | 575.73M |